However, the secretion of IL-17 along with other effector cytokines such as IFNγ can exert potent antitumor effects boosting tumor-specific T cell responses through enhanced dendritic and cytotoxic T cell recruitment to the tumor bed27. The gene discussed is IL17A; the disease is neoplasm.